Please login to the form below
Nichi-Iko
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.
AZ says target of $45bn sales by 2023 still achievable
patient prescriptions in the US and Germany and topping all biologics for asthma on that measure in Japan.
Novartis: pipeline will generate 60 filings in three years
The tally across the US, EU and Japan includes 26 projects that the drugmaker thinks have blockbuster sales potential that have already passed the proof-of-concept stage in clinical development. ... 1 – acquired as part of its $8.7bn takeover of AveXis
GSK’s says depot HIV injection works over three years
The new data, from the second of three pivotal trials intended to support a marketing application in Japan, showed that the drug was as effective as intravenous treatment with long-acting ... GSK says it remains on track to file for approval of
Roche’s new flu pill Xofluza approved in US
Discovered and developed by Shionogi, the drug is already approved in Japan, with Roche holding the marketing rights outside Japan and Taiwan.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Associate Medical Director
-
Highly Competitive
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Director, Market Access / HEOR - North-West
-
Negotiable
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
-
Medical/ Scientific Director
-
Salary TBC
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
Account Director
-
£48, 000 - £60, 000
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
-
Account Director
-
Excellent benefits
-
New Business Director - PR
-
Competitive Salary and benefits
Subscribe to our email news alerts
- Five things you didn't realise you already know about influencer marketing
- Innovation in merger control and the impact on the pharmaceutical sector
- Neuromodulation Devices Market Analysis, Segments, Growth and Value Chain 2017 – 2027
- Hematology Analyzer And Reagents Market Dynamics, Forecast, Analysis and Supply Demand 2017-2027
- Metastatic Bone Tumor Treatment Market Dynamics, Forecast, Analysis and Supply Demand 2017 – 2027
- Image-Based Cytometer Market size and Key Trends in terms of volume and value 2017 – 2027
PMHub
VCCP Health
We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
